Drug Trial Radar · NCT01429116
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Last checked: Nov 19, 2026Latest source record: Apr 21, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Planned (sponsor's estimate)
Start
Oct 2011
Primary completion
Jan 2015
Study completion Jan 2015
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Sep 5, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety of tasimelteon in male and female patients who suffer from Non-24-Hour Sleep-Wake Disorder.
Conditions
- Non-24-Hour Sleep-Wake Disorder
Interventions
tasimelteonDrug
20 mg tasimelteon capsules, PO daily for 24 months + 12 month optional extension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with Treatment-Emergent Adverse Events (AEs)Time frame: 24 months + 12 month optional extension
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Pulmonary Associates, PA
Phoenix, Arizona
SDS Clinical Trials Inc.
Orange, California
VA Palo Alto Health Care System/PAIRE (San Fransisco Bay Area)
Palo Alto, California
St. Johns Sleep Disorder Center - St. Johns Medical Plaza
Santa Monica, California
Radiant Research - Denver
Denver, Colorado
PAB Clinical Research Inc.
Brandon, Florida
Kendall South Medical Center, Inc.
Miami, Florida
Neurology Associates of Ormond Beach
Ormond Beach, Florida
Sleep Disorders Center Of Georgia
Atlanta, Georgia
Suburban Lung Associates SC (Chicago Metropolitan Area)
Elk Grove Village, Illinois
The Center for Sleep and Wake Disorders (Washington, D.C. Metropolitan Area)
Chevy Chase, Maryland
Brigham and Women's Hospital
Boston, Massachusetts
Michigan Head-Pain Neurological Institute
Ann Arbor, Michigan
St. Luke's Sleep Medicine and Research Center (St. Louis Metropolitan Area)
Chesterfield, Missouri
New York Eye and Ear Infirmary
New York, New York
Ohio Sleep Medicine Institute (Columbus Metropolitan Area)
Dublin, Ohio
Lynn Health Science Institute
Oklahoma City, Oklahoma
Columbia Research Group Inc.
Portland, Oregon
Center for Sleep Medicine at Chestnut Hill Hospital
Philadelphia, Pennsylvania
Consolidated Clinical trials
Pittsburgh, Pennsylvania
SleepMed, Inc. - Columbia
Columbia, South Carolina
Todd J. Swick, M.D., P.A.
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.